APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Therapeutic Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global HPV Therapeutic Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchHPV Therapeutic Vaccines Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Therapeutic Vaccines Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal HPV Therapeutic Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Therapeutic Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Therapeutic Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global HPV Therapeutic Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HPV Therapeutic Vaccines include Shanghai Bovax Biotechnology Co., Ltd., Sanofi Pasteur, Johnson and Johnson., Pfizer, GlaxoSmithKline plc, Wantai BioPharm, Serum Institute, Profectus BioSciences, Inc. and Merck & Co., Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global HPV Therapeutic Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HPV Therapeutic Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HPV Therapeutic Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the HPV Therapeutic Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

HPV Therapeutic Vaccines Segment by Company

Shanghai Bovax Biotechnology Co., Ltd.

Sanofi Pasteur

Johnson and Johnson.

Pfizer

GlaxoSmithKline plc

Wantai BioPharm

Serum Institute

Profectus BioSciences, Inc.

Merck & Co., Inc

ISA Pharmaceuticals

INOVIO Pharmaceuticals

Emergent BioSolutions

Astellas Pharma

2A Pharma AB

HPV Therapeutic Vaccines Segment by Type

Bivalent HPV vaccine

Quadrivalent HPV vaccine

HPV Therapeutic Vaccines Segment by Application

Man

Woman

HPV Therapeutic Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Therapeutic Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of HPV Therapeutic Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HPV Therapeutic Vaccines industry.

Chapter 3: Detailed analysis of HPV Therapeutic Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HPV Therapeutic Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HPV Therapeutic Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bivalent HPV vaccine Table 3. Key Players of Quadrivalent HPV vaccine Table 4. Global HPV Therapeutic Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Man Table 6. Key Players of Woman Table 7. Global HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global HPV Therapeutic Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 9. Global HPV Therapeutic Vaccines Market Share by Region (2021-2026) Table 10. Global HPV Therapeutic Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 11. Global HPV Therapeutic Vaccines Market Share by Region (2027-2032) Table 12. HPV Therapeutic Vaccines Industry Trends Table 13. HPV Therapeutic Vaccines Industry Drivers Table 14. HPV Therapeutic Vaccines Industry Opportunities and Challenges Table 15. HPV Therapeutic Vaccines Industry Restraints Table 16. Global HPV Therapeutic Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 17. Global HPV Therapeutic Vaccines Revenue Market Share by Company (2021-2026) Table 18. Global HPV Therapeutic Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global HPV Therapeutic Vaccines Key Company Head Office and Area Served Table 20. Global HPV Therapeutic Vaccines Company, Product Type & Application Table 21. Global HPV Therapeutic Vaccines Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global HPV Therapeutic Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global HPV Therapeutic Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 26. Global HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 27. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global HPV Therapeutic Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 31. Global HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 32. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2027-2032) Table 34. Shanghai Bovax Biotechnology Co., Ltd. Company Information Table 35. Shanghai Bovax Biotechnology Co., Ltd. Business Overview Table 36. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Portfolio Table 38. Shanghai Bovax Biotechnology Co., Ltd. Recent Development Table 39. Sanofi Pasteur Company Information Table 40. Sanofi Pasteur Business Overview Table 41. Sanofi Pasteur HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Sanofi Pasteur HPV Therapeutic Vaccines Product Portfolio Table 43. Sanofi Pasteur Recent Development Table 44. Johnson and Johnson. Company Information Table 45. Johnson and Johnson. Business Overview Table 46. Johnson and Johnson. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Johnson and Johnson. HPV Therapeutic Vaccines Product Portfolio Table 48. Johnson and Johnson. Recent Development Table 49. Pfizer Company Information Table 50. Pfizer Business Overview Table 51. Pfizer HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pfizer HPV Therapeutic Vaccines Product Portfolio Table 53. Pfizer Recent Development Table 54. GlaxoSmithKline plc Company Information Table 55. GlaxoSmithKline plc Business Overview Table 56. GlaxoSmithKline plc HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. GlaxoSmithKline plc HPV Therapeutic Vaccines Product Portfolio Table 58. GlaxoSmithKline plc Recent Development Table 59. Wantai BioPharm Company Information Table 60. Wantai BioPharm Business Overview Table 61. Wantai BioPharm HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Wantai BioPharm HPV Therapeutic Vaccines Product Portfolio Table 63. Wantai BioPharm Recent Development Table 64. Serum Institute Company Information Table 65. Serum Institute Business Overview Table 66. Serum Institute HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Serum Institute HPV Therapeutic Vaccines Product Portfolio Table 68. Serum Institute Recent Development Table 69. Profectus BioSciences, Inc. Company Information Table 70. Profectus BioSciences, Inc. Business Overview Table 71. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Portfolio Table 73. Profectus BioSciences, Inc. Recent Development Table 74. Merck & Co., Inc Company Information Table 75. Merck & Co., Inc Business Overview Table 76. Merck & Co., Inc HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Merck & Co., Inc HPV Therapeutic Vaccines Product Portfolio Table 78. Merck & Co., Inc Recent Development Table 79. ISA Pharmaceuticals Company Information Table 80. ISA Pharmaceuticals Business Overview Table 81. ISA Pharmaceuticals HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. ISA Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio Table 83. ISA Pharmaceuticals Recent Development Table 84. INOVIO Pharmaceuticals Company Information Table 85. INOVIO Pharmaceuticals Business Overview Table 86. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio Table 88. INOVIO Pharmaceuticals Recent Development Table 89. Emergent BioSolutions Company Information Table 90. Emergent BioSolutions Business Overview Table 91. Emergent BioSolutions HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Emergent BioSolutions HPV Therapeutic Vaccines Product Portfolio Table 93. Emergent BioSolutions Recent Development Table 94. Astellas Pharma Company Information Table 95. Astellas Pharma Business Overview Table 96. Astellas Pharma HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Astellas Pharma HPV Therapeutic Vaccines Product Portfolio Table 98. Astellas Pharma Recent Development Table 99. 2A Pharma AB Company Information Table 100. 2A Pharma AB Business Overview Table 101. 2A Pharma AB HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. 2A Pharma AB HPV Therapeutic Vaccines Product Portfolio Table 103. 2A Pharma AB Recent Development Table 104. North America HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 105. North America HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 106. North America HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 107. North America HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 108. North America HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America HPV Therapeutic Vaccines Market Size by Country (2021-2026) Table 110. North America HPV Therapeutic Vaccines Market Size by Country (2027-2032) Table 111. Europe HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 112. Europe HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 113. Europe HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 114. Europe HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 115. Europe HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe HPV Therapeutic Vaccines Market Size by Country (2021-2026) Table 117. Europe HPV Therapeutic Vaccines Market Size by Country (2027-2032) Table 118. China HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 119. China HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 120. China HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 121. China HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 123. Asia HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 124. Asia HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 125. Asia HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 126. Asia HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia HPV Therapeutic Vaccines Market Size by Country (2021-2026) Table 128. Asia HPV Therapeutic Vaccines Market Size by Country (2027-2032) Table 129. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 130. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 131. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021-2026) Table 135. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. HPV Therapeutic Vaccines Product Image Figure 2. Global HPV Therapeutic Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global HPV Therapeutic Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Bivalent HPV vaccine Image Figure 5. Quadrivalent HPV vaccine Image Figure 6. Global HPV Therapeutic Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global HPV Therapeutic Vaccines Market Share by Application: 2025 VS 2032 Figure 8. Man Image Figure 9. Woman Image Figure 10. Global HPV Therapeutic Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 12. Global HPV Therapeutic Vaccines Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global HPV Therapeutic Vaccines Market Share by Players in 2025 Figure 15. Global Top 5 and 10 HPV Therapeutic Vaccines Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global HPV Therapeutic Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2021-2032) Figure 19. Global HPV Therapeutic Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 22. North America HPV Therapeutic Vaccines Market Share by Type (2021-2032) Figure 23. North America HPV Therapeutic Vaccines Market Share by Application (2021-2032) Figure 24. North America HPV Therapeutic Vaccines Market Share by Country (2021-2032) Figure 25. United States HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 26. Canada HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 27. Mexico HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 28. Europe HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. Europe HPV Therapeutic Vaccines Market Share by Type (2021-2032) Figure 30. Europe HPV Therapeutic Vaccines Market Share by Application (2021-2032) Figure 31. Europe HPV Therapeutic Vaccines Market Share by Country (2021-2032) Figure 32. Germany HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 33. France HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 34. U.K. HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. Italy HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. Russia HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 38. China HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 39. China HPV Therapeutic Vaccines Market Share by Type (2021-2032) Figure 40. China HPV Therapeutic Vaccines Market Share by Application (2021-2032) Figure 41. Asia HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 42. Asia HPV Therapeutic Vaccines Market Share by Type (2021-2032) Figure 43. Asia HPV Therapeutic Vaccines Market Share by Application (2021-2032) Figure 44. Asia HPV Therapeutic Vaccines Market Share by Country (2021-2032) Figure 45. Japan HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 46. South Korea HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. India HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 50. Australia HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Country (2021-2032) Figure 55. Brazil HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 56. South Africa HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. Turkey HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. Argentina HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 60. UAE HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 61. Egypt HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 62. Chile HPV Therapeutic Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Bivalent HPV vaccine
  • Quadrivalent HPV vaccine
Applications
  • Man
  • Woman
Companies covered
  • Shanghai Bovax Biotechnology Co., Ltd.
  • Sanofi Pasteur
  • Johnson and Johnson.
  • Pfizer
  • GlaxoSmithKline plc
  • Wantai BioPharm
  • Serum Institute
  • Profectus BioSciences, Inc.
  • Merck & Co., Inc
  • ISA Pharmaceuticals
  • INOVIO Pharmaceuticals
  • Emergent BioSolutions
  • Astellas Pharma
  • 2A Pharma AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global HPV Therapeutic Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bivalent HPV vaccine
  5. 1.2.3 Quadrivalent HPV vaccine
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global HPV Therapeutic Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Man
  9. 1.3.3 Woman
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global HPV Therapeutic Vaccines Growth Trends by Region
  12. 1.5.1 Global HPV Therapeutic Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 HPV Therapeutic Vaccines Market Size by Region (2021-2026)
  14. 1.5.3 HPV Therapeutic Vaccines Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global HPV Therapeutic Vaccines Market Dynamics
  1. 2.1 HPV Therapeutic Vaccines Industry Trends
  2. 2.2 HPV Therapeutic Vaccines Industry Drivers
  3. 2.3 HPV Therapeutic Vaccines Industry Opportunities and Challenges
  4. 2.4 HPV Therapeutic Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global HPV Therapeutic Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global HPV Therapeutic Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global HPV Therapeutic Vaccines Key Company Head office and Area Served
  4. 3.4 Global HPV Therapeutic Vaccines Company, Product Type & Application
  5. 3.5 Global HPV Therapeutic Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global HPV Therapeutic Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 HPV Therapeutic Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 HPV Therapeutic Vaccines Tier 1, Tier 2, and Tier 3
4 HPV Therapeutic Vaccines Market by Type
  1. 4.1 Global HPV Therapeutic Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global HPV Therapeutic Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global HPV Therapeutic Vaccines Market Size Share by Type (2021-2032)
5 HPV Therapeutic Vaccines Market by Application
  1. 5.1 Global HPV Therapeutic Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global HPV Therapeutic Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global HPV Therapeutic Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Shanghai Bovax Biotechnology Co., Ltd.
  2. 6.1.1 Shanghai Bovax Biotechnology Co., Ltd. Company Information
  3. 6.1.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
  4. 6.1.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Portfolio
  6. 6.1.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Pasteur HPV Therapeutic Vaccines Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 Johnson and Johnson.
  14. 6.3.1 Johnson and Johnson. Company Information
  15. 6.3.2 Johnson and Johnson. Business Overview
  16. 6.3.3 Johnson and Johnson. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson and Johnson. HPV Therapeutic Vaccines Product Portfolio
  18. 6.3.5 Johnson and Johnson. Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer HPV Therapeutic Vaccines Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline plc
  26. 6.5.1 GlaxoSmithKline plc Company Information
  27. 6.5.2 GlaxoSmithKline plc Business Overview
  28. 6.5.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Product Portfolio
  30. 6.5.5 GlaxoSmithKline plc Recent Developments
  31. 6.6 Wantai BioPharm
  32. 6.6.1 Wantai BioPharm Company Information
  33. 6.6.2 Wantai BioPharm Business Overview
  34. 6.6.3 Wantai BioPharm HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Wantai BioPharm HPV Therapeutic Vaccines Product Portfolio
  36. 6.6.5 Wantai BioPharm Recent Developments
  37. 6.7 Serum Institute
  38. 6.7.1 Serum Institute Company Information
  39. 6.7.2 Serum Institute Business Overview
  40. 6.7.3 Serum Institute HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Serum Institute HPV Therapeutic Vaccines Product Portfolio
  42. 6.7.5 Serum Institute Recent Developments
  43. 6.8 Profectus BioSciences, Inc.
  44. 6.8.1 Profectus BioSciences, Inc. Company Information
  45. 6.8.2 Profectus BioSciences, Inc. Business Overview
  46. 6.8.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Portfolio
  48. 6.8.5 Profectus BioSciences, Inc. Recent Developments
  49. 6.9 Merck & Co., Inc
  50. 6.9.1 Merck & Co., Inc Company Information
  51. 6.9.2 Merck & Co., Inc Business Overview
  52. 6.9.3 Merck & Co., Inc HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Merck & Co., Inc HPV Therapeutic Vaccines Product Portfolio
  54. 6.9.5 Merck & Co., Inc Recent Developments
  55. 6.10 ISA Pharmaceuticals
  56. 6.10.1 ISA Pharmaceuticals Company Information
  57. 6.10.2 ISA Pharmaceuticals Business Overview
  58. 6.10.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
  60. 6.10.5 ISA Pharmaceuticals Recent Developments
  61. 6.11 INOVIO Pharmaceuticals
  62. 6.11.1 INOVIO Pharmaceuticals Company Information
  63. 6.11.2 INOVIO Pharmaceuticals Business Overview
  64. 6.11.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
  66. 6.11.5 INOVIO Pharmaceuticals Recent Developments
  67. 6.12 Emergent BioSolutions
  68. 6.12.1 Emergent BioSolutions Company Information
  69. 6.12.2 Emergent BioSolutions Business Overview
  70. 6.12.3 Emergent BioSolutions HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Emergent BioSolutions HPV Therapeutic Vaccines Product Portfolio
  72. 6.12.5 Emergent BioSolutions Recent Developments
  73. 6.13 Astellas Pharma
  74. 6.13.1 Astellas Pharma Company Information
  75. 6.13.2 Astellas Pharma Business Overview
  76. 6.13.3 Astellas Pharma HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Astellas Pharma HPV Therapeutic Vaccines Product Portfolio
  78. 6.13.5 Astellas Pharma Recent Developments
  79. 6.14 2A Pharma AB
  80. 6.14.1 2A Pharma AB Company Information
  81. 6.14.2 2A Pharma AB Business Overview
  82. 6.14.3 2A Pharma AB HPV Therapeutic Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 2A Pharma AB HPV Therapeutic Vaccines Product Portfolio
  84. 6.14.5 2A Pharma AB Recent Developments
7 North America
  1. 7.1 North America HPV Therapeutic Vaccines Market Size (2021-2032)
  2. 7.2 North America HPV Therapeutic Vaccines Market Size by Type
  3. 7.2.1 North America HPV Therapeutic Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America HPV Therapeutic Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America HPV Therapeutic Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America HPV Therapeutic Vaccines Market Size by Application
  7. 7.3.1 North America HPV Therapeutic Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America HPV Therapeutic Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America HPV Therapeutic Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America HPV Therapeutic Vaccines Market Size by Country
  11. 7.4.1 North America HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America HPV Therapeutic Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America HPV Therapeutic Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America HPV Therapeutic Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe HPV Therapeutic Vaccines Market Size (2021-2032)
  2. 8.2 Europe HPV Therapeutic Vaccines Market Size by Type
  3. 8.2.1 Europe HPV Therapeutic Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe HPV Therapeutic Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe HPV Therapeutic Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe HPV Therapeutic Vaccines Market Size by Application
  7. 8.3.1 Europe HPV Therapeutic Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe HPV Therapeutic Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe HPV Therapeutic Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe HPV Therapeutic Vaccines Market Size by Country
  11. 8.4.1 Europe HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe HPV Therapeutic Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe HPV Therapeutic Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe HPV Therapeutic Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China HPV Therapeutic Vaccines Market Size (2021-2032)
  2. 9.2 China HPV Therapeutic Vaccines Market Size by Type
  3. 9.2.1 China HPV Therapeutic Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China HPV Therapeutic Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China HPV Therapeutic Vaccines Market Share by Type (2021-2032)
  6. 9.3 China HPV Therapeutic Vaccines Market Size by Application
  7. 9.3.1 China HPV Therapeutic Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China HPV Therapeutic Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China HPV Therapeutic Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia HPV Therapeutic Vaccines Market Size (2021-2032)
  2. 10.2 Asia HPV Therapeutic Vaccines Market Size by Type
  3. 10.2.1 Asia HPV Therapeutic Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia HPV Therapeutic Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia HPV Therapeutic Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia HPV Therapeutic Vaccines Market Size by Application
  7. 10.3.1 Asia HPV Therapeutic Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia HPV Therapeutic Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia HPV Therapeutic Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia HPV Therapeutic Vaccines Market Size by Country
  11. 10.4.1 Asia HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia HPV Therapeutic Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia HPV Therapeutic Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia HPV Therapeutic Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa HPV Therapeutic Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst